| Idiopathic Anemia of Aging (IAA) (NCT00104169) | National Institute on Aging (NIA) | 2004-08-01 |
| Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) (NCT00093015) | Amgen | 2004-08-01 |
| Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients (NCT00233597) | AMAG Pharmaceuticals, Inc. | 2004-08-01 |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00077311) | Alliance for Clinical Trials in Oncology | 2004-08-01 |
| Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers (NCT00097747) | Affymax | 2004-08-01 |
| Iron Sucrose in Stage 3/4 Kidney Disease (NCT00202345) | Melbourne Health | 2004-08-01 |
| An Observational Study of Blood Management Techniques in Oncology Surgical Treatment (NCT00264095) | Janssen-Cilag B.V. | 2004-07-01 |
| Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT (NCT00236678) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-07-01 |
| Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients (NCT00318227) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2004-06-21 |
| A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia (NCT00210795) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-06-01 |
| Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients (NCT00255437) | AMAG Pharmaceuticals, Inc. | 2004-06-01 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors (NCT02554942) | Hoffmann-La Roche | 2004-06-01 |
| A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia (NCT00228995) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-06-01 |
| A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis (NCT00081471) | Hoffmann-La Roche | 2004-06-01 |
| A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients (NCT00081484) | Hoffmann-La Roche | 2004-06-01 |
| Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia. (NCT00210743) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-05-01 |
| Well Being of Obstetric Patients on Minimal Blood Transfusions (NCT00335023) | Sanquin Research & Blood Bank Divisions | 2004-05-01 |
| Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients (NCT00255424) | AMAG Pharmaceuticals, Inc. | 2004-05-01 |
| An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy. (NCT00210834) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-05-01 |
| Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh. (NCT00392418) | The Hospital for Sick Children | 2004-05-01 |
| Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women (NCT00148629) | Cornell University | 2004-04-01 |
| Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer (NCT00091858) | Amgen | 2004-04-01 |
| Severe Anemia Treatment Trials, Pakistan (NCT00116493) | Johns Hopkins Bloomberg School of Public Health | 2004-04-01 |
| Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients (NCT00666835) | Sandoz | 2004-04-01 |
| Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron. (NCT02146053) | Medical Research Council | 2004-03-01 |
| A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. (NCT00077623) | Hoffmann-La Roche | 2004-03-01 |
| Iron Supplementation of Marginally Low Birth Weight Infants (NCT00558454) | Umeå University | 2004-03-01 |
| A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy (NCT00118638) | Amgen | 2004-03-01 |
| Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients (NCT00303329) | Novartis Pharmaceuticals | 2004-03-01 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. (NCT00077766) | Hoffmann-La Roche | 2004-03-01 |
| Intermittent Preventive Treatment With Antimalarials in Kenyan Infants (NCT00111163) | Centers for Disease Control and Prevention | 2004-03-01 |
| A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy (NCT02761642) | Hoffmann-La Roche | 2004-02-29 |
| A Study of Mircera for the Treatment of Anemia in Dialysis Patients (NCT00077597) | Hoffmann-La Roche | 2004-02-01 |
| Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy (NCT00083486) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-02-01 |
| Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy (NCT00083434) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-02-01 |
| PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy (NCT00388336) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-02-01 |
| Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients. (NCT00210756) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-02-01 |
| Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy (NCT00110955) | Amgen | 2004-02-01 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients (NCT00077610) | Hoffmann-La Roche | 2004-02-01 |
| Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum (NCT00189371) | AGO Study Group | 2004-02-01 |
| A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia (NCT00117039) | Amgen | 2004-01-01 |
| Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. (NCT00223938) | Sanofi | 2003-12-30 |
| Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. (NCT00145652) | Sundsvall Hospital | 2003-12-01 |
| Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia (NCT00212862) | Ortho Biotech Products, L.P. | 2003-12-01 |
| A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa) (NCT00338468) | Ortho Biotech Products, L.P. | 2003-11-01 |
| Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced (NCT00210002) | Institut Claudius Regaud | 2003-11-01 |
| Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma (NCT00400686) | The Cleveland Clinic | 2003-09-01 |
| Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU) (NCT00091910) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-09-01 |
| Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia (NCT00236977) | American Regent, Inc. | 2003-08-01 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer (NCT00070382) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India (NCT00198835) | Johns Hopkins Bloomberg School of Public Health | 2003-08-01 |
| Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia (NCT00086086) | Amgen | 2003-08-01 |
| Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia (NCT00338299) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-08-01 |
| A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy (NCT00216541) | Janssen-Cilag B.V. | 2003-08-01 |
| Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease (NCT00071032) | Rutgers, The State University of New Jersey | 2003-07-01 |
| Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly (NCT03907553) | Istituto Clinico Humanitas | 2003-07-01 |
| A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy (NCT02767765) | Hoffmann-La Roche | 2003-06-01 |
| Epoetin Alfa in Treating Anemia in Patients With Solid Tumors (NCT00058331) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Iron Supplementation Among Low-Income Postpartum Women (NCT00207610) | Centers for Disease Control and Prevention | 2003-06-01 |
| Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients (NCT00223964) | Watson Pharmaceuticals | 2003-06-01 |
| A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. (NCT00341055) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-06-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00258440) | OHSU Knight Cancer Institute | 2003-05-01 |
| A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda (NCT00118027) | London School of Hygiene and Tropical Medicine | 2003-05-01 |
| Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in Mexico (NCT00508131) | Instituto Nacional de Salud Publica, Mexico | 2003-05-01 |
| Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients (NCT00224003) | Watson Pharmaceuticals | 2003-04-01 |
| Study of Aranesp to Treat Anemia in Prostate Cancer Patients. (NCT00245895) | University of Washington | 2003-04-01 |
| Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot (NCT00126334) | Medstar Health Research Institute | 2003-04-01 |
| Iron-Deficiency Anemia in Infants in Two Weekly Programs (NCT00655408) | Sao Jose do Rio Preto Medical School | 2003-04-01 |
| An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks (NCT00338416) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-03-01 |
| Intermittent Antimalaria Treatment With SP in African Children (NCT00168948) | Charite University, Berlin, Germany | 2003-03-01 |
| Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children (NCT00822380) | Universidad Autonoma de Queretaro | 2003-03-01 |
| An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks (NCT00337948) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-02-01 |
| Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia (NCT00315484) | Ortho Biotech Products, L.P. | 2003-02-01 |
| Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy (NCT00236951) | American Regent, Inc. | 2003-02-01 |
| Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants (NCT00206739) | Bernhard Nocht Institute for Tropical Medicine | 2003-01-01 |
| Treatment of Chronic Anemia With Epoetin Alfa in Elderly (NCT00337441) | Research and Education Foundation of Michael Reese Hospital | 2003-01-01 |
| A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy (NCT00117624) | Amgen | 2002-12-01 |
| A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer (NCT00246597) | Ortho Biotech Products, L.P. | 2002-12-01 |
| RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia (NCT00495378) | Ortho Biotech Products, L.P. | 2002-11-01 |
| Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy (NCT00120705) | Amgen | 2002-11-01 |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy (NCT00121030) | Amgen | 2002-10-01 |
| An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) (NCT00317902) | Ortho Biotech Products, L.P. | 2002-10-01 |
| Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy (NCT00120679) | Amgen | 2002-10-01 |
| Treatment for Patients Suffering From Anemia Due to Chemotherapy (NCT00120692) | Amgen | 2002-10-01 |
| Intravenous Treatment of Anemia in Pregnancy (NCT03317210) | University of Zurich | 2002-09-01 |
| (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy (NCT00354341) | Hoffmann-La Roche | 2002-09-01 |
| A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® (NCT00117117) | Amgen | 2002-09-01 |
| Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia (NCT00117234) | Amgen | 2002-09-01 |
| Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects (NCT00119587) | Amgen | 2002-08-01 |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer (NCT00046969) | AGO Study Group | 2002-07-01 |
| Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis (NCT00236938) | American Regent, Inc. | 2002-07-01 |
| Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin (NCT00239616) | American Regent, Inc. | 2002-06-05 |
| Iron-Biofortified Rice Intervention in the Philippines (NCT04623918) | Cornell University | 2002-06-01 |
| A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects (NCT00117247) | Amgen | 2002-06-01 |
| Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy (NCT00224068) | Watson Pharmaceuticals | 2002-05-01 |
| Darbepoetin Alfa and Anemia of Cancer (NCT00989092) | Amgen | 2002-05-01 |
| Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis (NCT00111995) | Amgen | 2002-05-01 |
| Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer (NCT00031980) | Alliance for Clinical Trials in Oncology | 2002-03-01 |
| A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. (NCT00048048) | Hoffmann-La Roche | 2002-03-01 |
| Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) (NCT00211120) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-03-01 |